市場調查報告書
商品編碼
1298694
兒科介入心臟病學市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Pediatric Interventional Cardiology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球兒科介入心臟病學市場規模達到25億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到37億美元,在2023-2028年期間表現出6.5%的成長率(CAGR)。
小兒介入心臟病學是心臟病學的一個分支,涉及使用特定的基於導管的技術來治療18歲以下的嬰兒、兒童和青少年的心臟疾病。它們包括球囊血管成形術、線圈封堵術、支架植入術和主動脈瓣狹窄。與傳統的心臟病治療相比,小兒介入心臟病學更具有微創性,從而減少手術後的併發症。因此,它們被廣泛用於進行血管成形術、瓣膜成形術、冠狀動脈血栓切除術和先天性心臟缺陷矯正手術,遍及臨床測試實驗室、醫院、心臟中心和研究機構。
兒童各種先天性心臟病的發生率越來越高,如房間隔缺損(ASD)、房室管缺損、動脈導管未閉(PDA)和室間隔缺損(VSD),這是推動小兒介入心臟病學市場成長的關鍵因素之一。新穎和更有效的小兒介入心臟病學設備,包括導管、生物可吸收支架、導絲、球囊、支架、血管封閉設備、動脈瘤切除設備的推出,是另一個主要的成長誘導因素。與此相呼應,患者對非侵入性醫療程序的趨勢轉變,以及對相關好處認知的提高,如降低感染風險、縮短術後恢復時間和避免大面積疤痕,也推動了市場成長。其他因素,包括醫療支出的增加和各國政府為加快監管程序而採取的許多計劃,都為市場創造了積極的前景。廣泛的研究和開發(R&D)活動、消費者醫療保健支出的增加、政府和非政府組織(NGO)為加強現有的醫療保健基礎設施而進行的投資以及心臟病學領域的重大技術進步,也是市場的驅動力。
The global pediatric interventional cardiology market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.
Pediatric interventional cardiology is a subset of cardiology that involves the use of specific catheter-based techniques to treat heart disorders in infants, children, and adolescents upto 18 years of age. They include balloon angioplasty, coil occlusion, stent implantation, and aortic valve stenosis. As compared to conventional cardiological treatments, pediatric interventional cardiology is more minimally invasive, thus reducing post-surgerycomplications. Consequently, they are extensively employed for performing angioplasty, valvuloplasty, coronary thrombectomy, and congenital heart defect correction procedures across clinical testing laboratories, hospitals, cardiac centers, and research institutes.
Theincreasing instances of various congenital cardiac diseases in children, such as atrial septal defect (ASD), atrioventricular canal defect, patent ductus arteriosus (PDA), and ventricular septal defect (VSD) represent one of the key factors driving the pediatric interventional cardiology market growth. The introduction of novel and more efficient pediatric interventional cardiology devices, including catheters, bio-absorbable stents, guidewires, balloons, stents, vascular closure devices, atherectomy devices is acting as another major growth-inducing factor.In line with this, the shifting inclination of patients toward non-invasive medical treatment procedures, along with the rising awareness regarding the associated benefits, such as lower risk of infection, shorter postoperative recovery times, and avoidance of large scars is also driving the market growth. Other factors, including rising healthcare expenditure and the numerous initiatives being undertaken by governments of various nations to speed-up regulatory procedures, are creating a positive outlook for the market. The market is also driven by extensive research and development (R&D) activities, increasing consumer healthcare expenditure and investments by governments and non-government organizations (NGOs) for strengthening the existing healthcare infrastructure, and significant technological advancements in the field of cardiology.
IMARC Group provides an analysis of the key trends in each sub-segment of the global pediatric interventional cardiology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on device type, procedure and end use.
Closure Devices
Transcatheter Heart Valves
Atherectomy Devices
Catheters
Balloons
Stents
Others
Catheter-Based Valve Implantation
Congenital Heart Defect Correction
Angioplasty
Coronary Thrombectomy
Others
Clinical Testing Laboratories
Hospitals
Cardiac Centers
Pediatric Clinics
Research Institutions
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens Healthineers AG, Terumo Corporation and W. L. Gore & Associates Inc.
Key Questions Answered in This Report
1. What was the size of the global pediatric interventional cardiology market in 2022?
2. What is the expected growth rate of the global pediatric interventional cardiology market during 2023-2028?
3. What are the key factors driving the global pediatric interventional cardiology market?
4. What has been the impact of COVID-19 on the global pediatric interventional cardiology market?
5. What is the breakup of the global pediatric interventional cardiology market based on the device type?
6. What are the key regions in the global pediatric interventional cardiology market?
7. Who are the key players/companies in the global pediatric interventional cardiology market?